What actually helps low libido during perimenopause or menopause
The sermorelin glutathione stack produces modest, incremental improvements in body composition, sleep quality, and subjective energy over 1216 weeks when combined with structured resistance training and adequate protein intake (1.62.2 g/kg daily)
Resistance training helps shift the ratio toward fat loss specifically, which may restart scale movement even when total caloric intake has not changed
Semaglutide, a long-acting GLP-1 agonist, exhibited a sustained weight decrease of approximately 15% of body weight in clinical studies, whereas tirzepatide, a combination GIP/GLP-1 agonist, attained a weight loss of up to 22.5% in the SURMOUNT trials [36,37]
For example, clinical trials show the following average weight loss results over 72 weeks: Saxenda : Around 8% of body weight Wegovy : Nearly 15% Zepbound : Up to 21% But its not just about weight loss
Epithalon vs GHK-Cu: Anti-Aging Peptide Research Comparison Epithalon vs GHK-Cu anti-aging research compared
